The Allstate Corporation (NYSE: ALL), initiation of coverage, Nov 21, 2026

The price assumes a 96% combined ratio; we see 94% and 18% upside

Allstate is a top-four US personal-lines insurer, earning about $60 billion of premiums a year. At $266.59 the shares imply a 96.0% mid-cycle combined ratio and a 15.7% return on equity, against our 94.0% and 18.7%.

Our rating
Buy
12-month target
$309.41
Price, Nov 18, 2026
$266.59
Expected return, with dividend
+18%

By Penmark Team

ALLBuyTarget $309.41+18% expectedFull report

What Allstate is now

A car and home insurer whose profit margins swing hard with the cycle

Allstate insures 39.3 million auto, home and other policies, collecting premiums up front and investing them in an $87.4 billion portfolio until claims are paid. Auto is 64% of FY26 premiums and home 29%.

Repair inflation pushed claims and costs to 106.1% of premiums in 2022. Rate rises and cost cuts took that combined ratio to 84.9% in 2025, and we expect it to drift back toward 94%.

Auto brings most of the premiums
FY26 earned premiums: $60.1bn$38.5bn auto
AutoHomeownersOther lines

Property-Liability earned premiums, our FY26 estimate. Source: Allstate filings; Penmark Research estimates.

The combined ratio swings through the insurance cycle
106.1%84.4%93.3%2021202320252028
ReportedOur estimate2017 to 2025 average, 94.4%

The combined ratio is claims and expenses as a share of premiums; below 100% is profitable. Excludes purchased intangibles. Source: Allstate 10-K filings; Penmark Research estimates.

How Allstate makes money (page 7)

What you are really buying

Book value and excess returns support $306, well above the $267 price

We value Allstate on residual income: book value plus the profits it earns above a 9.21% cost of equity. That gives $305.91 a share today, 14.7% above the $266.59 close.

A simple 10.9 times peer earnings multiple gives only $243.87, because it gives no credit for book value growth, rising bond yields or buybacks. Only that check and our bad case sit below the price.

Our value against the price and a peer check
Peer P/E check$243.87Today’s price$266.59Our base value$305.91

Residual income adds the present value of profit above the cost of equity to adjusted book value. The peer check applies the 10.9x US P&C peer median trailing P/E to normalised earnings of $22.37. Source: Signals (19 Nov 2026); Penmark Research.

How residual income values Allstate (page 22)

Where we disagree: the combined ratio

Margins should settle near 94%, two points better than the price assumes

At $266.59 the shares price a 96.0% mid-cycle combined ratio, worse than the 94.4% average from 2017 to 2025, which included the 2022 trough. We use 94.0%.

The expense ratio has fallen 3.3 points, from 24.6% to 21.4%, and auto rate filings have restarted in 39 locations. Each point is worth about $19.20 a share, so the gap is worth $39.32.

Mid-cycle combined ratio, three views
Price implies96.0%2017–25 average94.4%Our base case94.0%

Lower is better: the combined ratio is claims and expenses as a share of premiums. The 2017 to 2025 average excludes purchased intangibles. Source: Allstate filings; Penmark Research.

Why 94% is the right mid-cycle ratio (page 16)

Where we disagree: book value growth

Higher yields and buybacks keep book value per share compounding fast

The $87.4 billion portfolio reprices from a 4.30% yield in 2025 to 5.00% by 2030, adding about $0.3 billion of investment income a year. Even as earnings normalise, returns stay near 19%.

About $11 billion of payouts in 2027 and 2028 cut diluted shares 22% by 2030. Adjusted book value per share climbs from $128.26 to $214.95.

Adjusted book value per share keeps rising
$75.252024$107.302025$136.432026$151.622027$170.442028
ReportedOur estimate

Adjusted book value excludes unrealised bond gains and losses. Source: Allstate filings; Penmark Research estimates.

Yields, payouts and book value (page 17)

Where we disagree: near-term earnings

Reserve releases and policy growth put earnings about 7% above analysts

Analysts take management’s advice not to model reserve releases literally. Yet auto releases reached 8.2% of premiums in the first nine months of 2026, and October catastrophes were only $232m.

We expect $40.63 of earnings per share in 2026 and $29.46 in 2027, against analysts’ $37.90 and $27.58. Our releases fade to zero from 2029, so our value does not rely on them.

Adjusted earnings per share, ours against analysts
$34.832025$40.63$37.902026$29.46$27.582027$31.322028
ReportedOur estimateAnalysts’ forecast

Adjusted EPS. Analysts’ forecasts are MarketBeat (2026) and Zacks Research (2027) consensus, 17–18 Nov 2026. Source: Allstate filings; Penmark Research estimates.

Reserve releases and policy growth (page 18)

The odds

The middle and good cases both clear the price; the bad case costs 17%

We weight a $220.58 bad case at 30%, a $329.12 middle case at 50% and a $393.35 good case at 20%. The bad case repeats the 2022 auto trough at a 103.6% underlying ratio.

Weighting the three gives $287.58 today, which rolls forward to our $309.41 target: 16.1% above the $266.59 close, or 17.8% including the dividend.

  • Good, 20%The auto underlying ratio holds near 92%, the mid-cycle combined ratio is 92.5%, reserve releases continue, weather is benign and the yield reaches 5.1%.
  • Middle, 50%The auto combined ratio drifts to the mid-90s by 2028, the mid-cycle ratio is 94.0%, releases fade by 2029 and yields reach 5.0%.
  • Bad, 30%Auto loss costs outrun rate, 2028 repeats the 2022 trough at 103.6%, reserves are added, catastrophes return to 2023 levels and the mid-cycle ratio is 96.5%.
Where the price could be in 12 months
−$46.01 down+$126.76 upToday $266.59$220.58Bad case$329.12Middle case$393.35Good caseOur target $309.41

Circle size shows how likely we think each case is. Case values are 12-month values; the target weights all three and adds 12 months of expected return at a 9.21% cost of equity less a 1.62% dividend yield. Source: Penmark Research.

How we reach the $309 target (page 2)

What would change our mind

A one-point rise in the cost of equity would end the Buy on its own

February’s fourth-quarter results test our $11.26 quarterly earnings forecast and whether a new buyback follows. April shows whether rate filings in 39 locations hold the auto underlying ratio near 93%.

We would move to Hold if the cost of equity rose a point, or if the auto underlying ratio broke 95.5% in early 2027 without matching rate approvals.

What bears get right. A 1-point higher cost of equity cuts our target to $278.24, a Hold. A deeper auto loss-cost cycle that repeats 2022 drives the bad case, worth $205.02 a share today.
Dates to watch
  1. We expect $11.26 of earnings per share against about $8.49 implied by analysts, and a new buyback.

  2. Auto rate restarts should keep the auto underlying ratio at 93.0% or better.

  3. Shows whether the combined ratio holds near 92% to 94%, or slips toward the 96% priced in.

  4. We expect $29.46 of earnings per share, 6.8% above analysts’ $27.58.

Catalysts and risks (page 24)

Inside the full report

What each page covers after the summary on pages 1 and 2. Each opens the full report at that page.

See all 25 pages
  1. 3Adjusted ROE settles near 20% while EPS sits about 7% above consensus
  2. 4Allstate trades near its five-year book multiple despite a lower expense base
  3. 5The thesis in four charts: BVPS growth, shallower cycle, rising NII and policy gains
  4. 6Four debates separate our $309 target from today's $267 price
  5. 7How a 95-year-old Sears side project turned a 107% underwriting trough into a 38% ROE engine
  6. 8Portfolio simplification left a focused personal-lines insurer with an $87bn portfolio
  7. 9Auto and homeowners generate 93% of premiums; policy growth and rate drive top line
  8. 10A $550bn+ US personal-lines market exits a historic hard market into mid-cycle normalisation
  9. 11Allstate holds #2 US homeowners and #4 auto share with three-channel reach
  10. 1292% of CEO pay is at risk, backed by a stake worth 129 times salary (proxy basis)
  11. 13Earnings and ~$9bn of holdco liquidity fund $11bn of FY27E-FY28E payouts
  12. 14Book-value growth from auto margins, not multiple expansion, drove three-year gains
  13. 15Sector and company factors explain 97% of weekly variance; S&P 500 explains just 3%
  14. 16Personal-lines margins should normalise near 94%, two points better than priced
  15. 17Higher yields and retained earnings double adjusted BVPS to $215 as payouts reach $11bn
  16. 18Reserve releases and 3% policy growth buffer FY26E-27E, though conviction stays Low
  17. 19Underwriting recovery restored GAAP-to-adjusted alignment and cut leverage to 18%
  18. 20Premiums compound 6% annually while adjusted EPS troughs near $29 in FY27E
  19. 21Combined ratio (±$38/sh) and cost of equity (+$41/−$33/sh) drive valuation
  20. 22Residual income values Allstate at $306 base; the stock prices a 96% combined ratio
  21. 23Peer trailing P/E yields $244 (-20% vs base) by omitting future investment and book growth
  22. 24Five dated catalysts resolve our thesis; auto severity and rates are the binding risks
  23. 25Top three asset managers hold 28% of shares; short interest sits at four days to cover
  24. 26Full explicit model: underwriting normalises while BVPS compounds to $215 by FY30E
  25. 27GAAP reconciliation, insurance definitions and Penmark methodology summary

Penmark Research. This summary draws on our initiation report on The Allstate Corporation, published Nov 21, 2026. It is not investment advice. Analyst certification, rating definitions and important disclosures are in the full report.

Sign in to Penmark